HT6-27693-07519
3 vaccinations
5 coded responses
34 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 949 / CA
- Registered
- 2021-08-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
3GD-19821-37965
Child or adolescent in my care · Male · 2021-08-24
67N-29343-69547
Child or adolescent in my care · Male · 2022-01-20
EXX-22539-96185
Child or adolescent in my care · Male · 2022-06-20
Timeline
-
2021-08-24
Registered in v-safe
-
2021-08-28
Dose 1 — Pfizer-BioNTech
- 2021-08-28
- 2021-08-29
- 2021-08-30
-
2021-08-31
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Headache, NauseaFree text: Really mild and my period eta is Thursday so that contributes alot tooMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-11
-
2021-09-18
Dose 2 — Pfizer-BioNTech
- 2021-09-18
-
2021-09-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-24
- 2021-09-27
- 2021-10-02
-
2021-10-09
Survey response — day 21, dose 2MedDRA: Cough — Feeling: GoodFree text: Dry coughingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Survey response — day 28, dose 2MedDRA: Cough, Nasopharyngitis — Feeling: GoodFree text: Cold coughMedDRA releases: 2024-11 · check-in free text available
- 2021-10-23
- 2021-10-30
-
2021-12-18
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Unevaluable event — Feeling: FairFree text: Hormones and a coldMedDRA releases: 2024-11 · check-in free text available
-
2022-03-01
Dose 3 — Pfizer-BioNTech
-
2022-03-02
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Swollen armpitMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-03-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2022-03-05
- 2022-03-06
- 2022-03-07
- 2022-03-16
- 2022-03-29
- 2022-04-05
- 2022-04-12
- 2022-06-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-28 | Pfizer-BioNTech | No |
| 2 | 2021-09-18 | Pfizer-BioNTech | No |
| 3 | 2022-03-01 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Really mild and my period eta is Thursday so that contributes alot too
Release 10 — day 21, dose 2
Symptoms: Dry coughing
Release 10 — day 28, dose 2
Symptoms: Cold cough
Release 10 — 3 months, dose 2
Symptoms: Hormones and a cold
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen armpit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Unevaluable event | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release